SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |
| RWC Asset Management LLP | 2,050,000 | $3,774,152 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,051,000 | $3,832,088 | 0.10% |
| Calamos Advisors LLC | 10,115,000 | $18,895,528 | 0.09% |
| BALYASNY ASSET MANAGEMENT L.P. | 16,522,000 | $30,896,074 | 0.08% |
| Point72 Asset Management, L.P. | 9,007,000 | $16,802,227 | 0.06% |
| SSI INVESTMENT MANAGEMENT LLC | 444,000 | $829,392 | 0.05% |
| LORD, ABBETT & CO. LLC | 4,674,000 | $8,731 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,147,000 | $26,436,157 | 0.03% |
| PUTNAM INVESTMENTS LLC | 1,778,000 | $3,321,304 | 0.01% |
| LOOMIS SAYLES & CO L P | 22,406 | $2,903 | 0.01% |
This page lists SAREPTA THERAPEUTICS INC's shareholders in Q4 2022. To view SAREPTA THERAPEUTICS INC's shareholder history, click here.